Most recent

ONORM EN ISO 10993-18:2021

Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)


This document lays down a framework for the identification and, where appropriate, quantification of the components of a medical device, which enables the identification of biological hazards and the estimation and control of the biological risks posed by component materials. A largely gradual approach to chemical characterisation is used, which may include one or more of the following steps: - the identification of the manufacturing materials (configuration of the medical device); - the characterisation of the manufacturing materials by identifying and quantifying their chemical components (material composition); - the characterisation of the medical device in relation to chemical substances introduced during manufacture (e.B. mold release agents, manufacturing-related impurities, sterilisation residues); - estimation (under laboratory extraction conditions) of the potential of medical ...


CONTENT PROVIDER
Austrian Standards Institute [on]

Others Also Bought
Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization (ISO 10993-10:2010); ...
Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood
Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
Document History
Revises:
  • ONORM EN ISO 10993-18:2020
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.